HighTower Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-22,904
Closed -$62.5K 3779
2025
Q1
$62.5K Sell
22,904
-1,576
-6% -$5.65K ﹤0.01% 3427
2024
Q4
$104K Sell
24,480
-5,224
-18% -$19.9K ﹤0.01% 3367
2024
Q3
$87K Hold
29,704
﹤0.01% 3337
2024
Q2
$103K Hold
29,704
﹤0.01% 3199
2024
Q1
$85K Sell
29,704
-295
-1% -$910 ﹤0.01% 3185
2023
Q4
$106K Sell
29,999
-100
-0.3% -$287 ﹤0.01% 3184
2023
Q3
$79K Sell
30,099
-600
-2% -$2.11K ﹤0.01% 3152
2023
Q2
$120K Buy
30,699
+5,700
+23% +$18.1K ﹤0.01% 3039
2023
Q1
$84K Hold
24,999
﹤0.01% 2975
2022
Q4
$89K Sell
24,999
-3,950
-14% -$16.9K ﹤0.01% 2952
2022
Q3
$115K Hold
28,949
﹤0.01% 2737
2022
Q2
$128K Sell
28,949
-464
-2% -$3.35K ﹤0.01% 2734
2022
Q1
$251K Buy
29,413
+2,049
+7% +$14.4K ﹤0.01% 2659
2021
Q4
$241K Sell
27,364
-3,099
-10% -$29.5K ﹤0.01% 2624
2021
Q3
$318K Sell
30,463
-80,075
-72% -$699K ﹤0.01% 2369
2021
Q2
$1.16M Buy
+110,538
New +$1.09M ﹤0.01% 1551

Other funds holding SRTA

HighTower Advisors's SRTA Position: Q2 2025 in Review

HighTower Advisors sold out of Strata Critical Medical Inc (SRTA) in Q2 2025, closing a stake of 22,904 shares — an estimated $62.5K sold.

HighTower Advisors first reported a position in SRTA in Q2 2021 and held it in 16 quarters. The position peaked at $1.16M in Q2 2021. 126 funds tracked by Wall St. Rank hold SRTA as of Q2 2025.

  • HighTower Advisors reported no remaining Strata Critical Medical Inc position as of Q2 2025 after selling out during the quarter.
  • HighTower Advisors sold 22,904 Strata Critical Medical Inc shares in Q2 2025, an estimated $62.5K.
  • HighTower Advisors first reported a position in Strata Critical Medical Inc in Q2 2021 and held it in 16 quarters.
  • HighTower Advisors's Strata Critical Medical Inc position peaked at $1.16M in Q2 2021.
  • 126 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2025.

Based on HighTower Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.